Pecha Kuka Method About Percutaneous Endoscopic Gastrostomy for Caregivers Who Care for Palliative Care Patients

June 7, 2024 updated by: Gülcan Bahçecioğlu Turan, Firat University

Examination of the Effectiveness of Training Given to Caregivers About Percutaneous Endoscopic Gastrostomy Using the Pecha Kuka Method to Caregivers Who Care for Palliative Care Patients

Palliative care; It was started by Dame Cicely Saunders in the 1960s as a hospice for community-based provision. Today, palliative care is defined as care that begins with the patient's diagnosis, symptom management is carried out effectively, and a comprehensive, supportive, humanistic approach is based on the individual and his family. When the literature was examined, no study was found that evaluated the effectiveness of the training given by the Pecha Kuka method to caregivers caring for palliative care patients about percutaneous endoscopic gastrostomy. In addition, it is thought that the results of this research will shed light on identifying problems related to feeding practices in patients fed with PEG tubes and identifying misinformation and practices of caregivers. Determining the knowledge level and initiatives of caregivers regarding percutaneous endoscopic gastrostomy tube feeding practices will contribute to the development of educational activities and effective strategies. Study results may provide important data regarding improving the quality of care given to patients and caregivers after discharge and controlling complication rates.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Center
      • Elazığ, Center, Turkey, 25240
        • Fırat university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Accepting research
  • Being a relative of a palliative care patient
  • Ability to communicate adequately

Exclusion Criteria:

  • The patient's relative has a disability (such as vision, speech and hearing) that prevents them from communicating.
  • No psychiatric problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Training Given with the Pecha Kucha Method
Pecha Kucha Method training was given
No Intervention: Control
No training was given on the Pecha Kucha Method

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation Form for Feeding Practices with Percutaneous Endoscopic Gastrostomy Tube:
Time Frame: 4 week
This data collection tool was created by researchers to evaluate the nutritional practices of individuals caring for patients fed through PEG tubes. Storage of the enteral nutrition product, duration of use after opening, dressing the feeding tube, rotating the plate 360 degrees during dressing, positioning the patient during feeding, checking the number written at the entrance of the feeding tube every time the nutritional product is given to the patient, use of nutritional products, duration of administration of the enteral nutrition product
4 week
Visual Analog Scale -Anxiety:
Time Frame: 4 week
Developed by Cline et al. It consists of a horizontal line 10 cm long. The left side contains the labels "no anxiety" and the right side includes the labels "I feel a lot of anxiety". The VAS value is determined by measuring the distance between the leftmost tip of the scale and the marked point. Values range from 0 to 10, with higher values indicating increased anxiety
4 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2024

Primary Completion (Actual)

March 13, 2024

Study Completion (Actual)

June 3, 2024

Study Registration Dates

First Submitted

February 23, 2024

First Submitted That Met QC Criteria

March 27, 2024

First Posted (Actual)

April 1, 2024

Study Record Updates

Last Update Posted (Actual)

June 11, 2024

Last Update Submitted That Met QC Criteria

June 7, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2024/03-17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Palliative Care

Clinical Trials on Pecha Kucha

Subscribe